OS Therapies Inc (OSTX)

Price, with every insider trade on it

Closing prices, 12 months · point at a dot for who traded, or at the line for the close

1.62 on 9 Oct 2026

0 buys0 sales at will0 planned sales

Fiscal year 2025, ended 31 Dec 2025, as filed

Net income

$28.75M

Free cash flow

$14.70M

Fiscal years, as filed with the SEC · point at a year for the detail

RevenueNet incomeLoss

From Form 4, most recent first

Date	Insider	Type	Value	Of own stake
7 May 2025	Auerbach Shalom 10% owner	Sold at will	$163.92K	3.0%
10 Apr 2025	Auerbach Shalom 10% owner	Sold at will	$13.90K	0.4%
9 Apr 2025	Auerbach Shalom 10% owner	Sold at will	$67.67K	1.8%
14 Feb 2025	Auerbach Shalom 10% owner	Sold at will	$284.30K	4.0%
15 Jan 2025	Auerbach Shalom 10% owner	Sold at will	$112.61K	0.7%

17out of 100

Profitability 0

Financial strength 10

Growth n/a

Insiders 50

Strongest on insiders (50), weakest on profitability (0). A score of the business, not of the price.

Last 12 months

Only here

Bought

$0.00

0 buys, 0 buyers

Sold

$0.00

0 sales

Planned sales

n/a

under a 10b5-1 plan